WallStreetZenWallStreetZen

NYSEMKT: CHRO
Channel Therapeutics Corp Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Channel Therapeutics earnings were -$8.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CHRO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.9M, up 13.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CHRO reported annual earnings of -$8.0M, with 7.8% growth.

CHRO earnings history

Current Revenue
$0.0
Current Earnings
-$8.0M
Current Profit Margin
0%

CHRO Return on Equity

Insufficient data to display

CHRO undefined

Current Company
-313.7%
Current Industry
-0.4%
CHRO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CHRO announces earnings.

CHRO undefined

Current Company
264.14%
Current Industry
5.9%
CHRO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CHRO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CHRO-$7.17M-$7.96MN/A-$1.43
TSBX-$68.97M-$70.84MN/A-$3.07
LYRA-$92.93M-$93.44MN/A-$1.43
EVGN-$10.63M-$16.49MN/A-$2.89
SLXN-$12.55M-$16.52MN/A-$26.36
View Top Biotech Stocks

Channel Therapeutics Earnings Reports & History FAQ

What were Channel Therapeutics's earnings last quarter?

Channel Therapeutics (NYSEMKT: CHRO) reported Q4 2024 earnings per share (EPS) of -$0.32, up 87.4% year over year. Total CHRO earnings for the quarter were -$1.93 million. In the same quarter last year, Channel Therapeutics's earnings per share (EPS) was -$2.54.

If you're new to stock investing, here's how to buy Channel Therapeutics stock.

Is Channel Therapeutics profitable or losing money?

As of the last Channel Therapeutics earnings report, Channel Therapeutics is currently losing money. Channel Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$7.96 million, a 7.78% increase year over year.

What was CHRO's earnings growth in the past year?

As of Channel Therapeutics's earnings date in Q2 2025, Channel Therapeutics's earnings has grown year over year. CHRO earnings in the past year totalled -$7.96 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.